In This Article:
Global markets have recently shown signs of optimism as trade tensions between major economies appear to be easing, leading to a rebound in U.S. equities and positive sentiment across several indices. Amidst these developments, investors are increasingly exploring opportunities beyond the traditional market leaders. Penny stocks, though an older term, continue to represent smaller or newer companies that can offer significant value when they possess strong financial foundations and clear growth potential.
Top 10 Penny Stocks Globally
| Name | Share Price | Market Cap | Financial Health Rating |
| CNMC Goldmine Holdings (Catalist:5TP) | SGD0.42 | SGD170.22M | ★★★★★☆ |
| Yangzijiang Shipbuilding (Holdings) (SGX:BS6) | SGD2.23 | SGD8.78B | ★★★★★☆ |
| Angler Gaming (NGM:ANGL) | SEK3.76 | SEK281.94M | ★★★★★★ |
| SKP Resources Bhd (KLSE:SKPRES) | MYR0.89 | MYR1.39B | ★★★★★☆ |
| NEXG Berhad (KLSE:NEXG) | MYR0.345 | MYR1B | ★★★★★★ |
| Sarawak Plantation Berhad (KLSE:SWKPLNT) | MYR2.42 | MYR675.26M | ★★★★★★ |
| Lever Style (SEHK:1346) | HK$1.06 | HK$668.81M | ★★★★★★ |
| Foresight Group Holdings (LSE:FSG) | £3.765 | £425.47M | ★★★★★★ |
| QinetiQ Group (LSE:QQ.) | £3.974 | £2.18B | ★★★★★☆ |
| EZZ Life Science Holdings (ASX:EZZ) | A$1.405 | A$64.63M | ★★★★★★ |
Click here to see the full list of 5,640 stocks from our Global Penny Stocks screener.
Underneath we present a selection of stocks filtered out by our screen.
Tian Tu Capital
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: Tian Tu Capital Co., Ltd. is a private equity and venture capital firm that invests in small and medium-sized companies across various growth stages, with a market cap of HK$2.05 billion.
Operations: The company's revenue segment primarily comprises Asset Management, which reported -CN¥662.24 million.
Market Cap: HK$2.05B
Tian Tu Capital, with a market cap of HK$2.05 billion, reported sales of CN¥42.43 million for 2024, showing a decline from the previous year. The company remains pre-revenue as its negative revenue stands at CN¥662.24 million. Despite being unprofitable with a net loss of CN¥891.49 million and negative return on equity, Tian Tu's debt situation has improved significantly over five years, reducing its debt to equity ratio from 56.1% to 15.6%. Short-term assets cover short-term liabilities but not long-term ones; however, the firm holds more cash than total debt and maintains stable weekly volatility at 10%.
-
Jump into the full analysis health report here for a deeper understanding of Tian Tu Capital.
-
Explore historical data to track Tian Tu Capital's performance over time in our past results report.
Broncus Holding
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: Broncus Holding Corporation is a medical device company that develops interventional pulmonology products for markets in Mainland China, the European Union, the United States, and internationally, with a market cap of approximately HK$1.16 billion.